Paper Details
- Home
- Paper Details
Preventive and Therapeutic Effects of the Retinoid X Receptor Agonist Bexarotene on Tumors.
Author: CaoXiaorong, GuoYuanyuan, LuanYuxia, QiLisi, ZhangPei
Original Abstract of the Article :
We present a review of recent investigations of anticancer drug bexarotene in this article. As one of the novel synthetic analogs of retinoids, bexarotene selectively binds to and activates the retinoid X receptor (RXRs) subfamilies, exerting a prophylactic and therapeutic effect on a large series o...See full text at original site
Dr.Camel's Paper Summary Blogラクダ博士について
ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。
* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。
引用元:
https://doi.org/10.2174/138920021702160114121706
データ提供:米国国立医学図書館(NLM)
Bexarotene: A Beacon of Hope in the Desert of Cancer
Cancer, a formidable foe, can feel like a vast and unforgiving desert. This research explores the potential of bexarotene, a retinoid X receptor agonist, as a beacon of hope in this challenging landscape.
Bexarotene: A Multifaceted Weapon Against Cancer
The study highlights the diverse therapeutic effects of bexarotene, targeting a wide range of tumors. This multifaceted approach is comparable to a desert explorer using a variety of tools and strategies to navigate the challenging terrain.
Dr. Camel's Conclusion
Bexarotene holds promise as a powerful tool in the fight against cancer. This research provides valuable insights into its mechanism of action and potential applications, offering a beacon of hope in the desert of cancer.
Date :
- Date Completed 2016-10-19
- Date Revised 2019-10-27
Further Info :
Related Literature
English
This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.